Mitogen Activated Protein Kinases Functions in Signal Transduction and Human Diseases
Mitogen-activated protein kinases (MAPK) are a large family of enzymes that function as signal transducers to regulate a diverse range of physiological responses. However, signaling via extracellular signal-regulated kinase (ERK), c-Jun amino terminal kinase (JNK), and p38 MAPK also underpin many di...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2020
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_68643 | ||
005 | 20210501 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20210501s2020 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-03928-071-1 | ||
020 | |a 9783039280704 | ||
020 | |a 9783039280711 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-03928-071-1 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
100 | 1 | |a Tikkanen, Ritva |4 edt | |
700 | 1 | |a Nikolic-Paterson, David |4 edt | |
700 | 1 | |a Tikkanen, Ritva |4 oth | |
700 | 1 | |a Nikolic-Paterson, David |4 oth | |
245 | 1 | 0 | |a Mitogen Activated Protein Kinases |b Functions in Signal Transduction and Human Diseases |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
300 | |a 1 electronic resource (276 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Mitogen-activated protein kinases (MAPK) are a large family of enzymes that function as signal transducers to regulate a diverse range of physiological responses. However, signaling via extracellular signal-regulated kinase (ERK), c-Jun amino terminal kinase (JNK), and p38 MAPK also underpin many disease processes. This Special Issue provides new insights into how MAPK signaling contributes to specific pathological processes across a range of conditions, including disorders of lung development, type 2 diabetes, proliferative skin diseases, cardiovascular diseases, and neurological diseases. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
653 | |a Rabdosia inflexa | ||
653 | |a inflammation | ||
653 | |a gastric ulcer | ||
653 | |a cytokines | ||
653 | |a MAPK | ||
653 | |a NF-κB | ||
653 | |a extracellular signal-regulated kinases 1/2 | ||
653 | |a hyperoxia | ||
653 | |a bronchopulmonary dysplasia | ||
653 | |a HPAECs | ||
653 | |a angiogenesis | ||
653 | |a cell cycle | ||
653 | |a SIRT1 | ||
653 | |a oxidative stress | ||
653 | |a psoriasis | ||
653 | |a antimicrobial peptide | ||
653 | |a cecropin A | ||
653 | |a tight junction protein | ||
653 | |a MEK/ERK signaling | ||
653 | |a porcine intestinal epithelial cell | ||
653 | |a extracellular signal-regulated kinase 5 (ERK5) | ||
653 | |a Kv4.2 | ||
653 | |a PC12 cells | ||
653 | |a infantile myofibromatosis | ||
653 | |a receptor tyrosine kinases | ||
653 | |a platelet-derived growth factor receptor | ||
653 | |a protein kinase inhibitors | ||
653 | |a sunitinib | ||
653 | |a erlotinib | ||
653 | |a FR180204 | ||
653 | |a U0126 | ||
653 | |a targeted therapy | ||
653 | |a apoptosis | ||
653 | |a ERK1/2 | ||
653 | |a JNKs | ||
653 | |a mitochondrial dysfunction | ||
653 | |a neurodegeneration | ||
653 | |a neuro-inflammation | ||
653 | |a p38 MAPKs | ||
653 | |a Parkinson's disease | ||
653 | |a mitogen-activated protein kinases (MAPKs) | ||
653 | |a MAPK kinetics | ||
653 | |a osteoclast differentiation | ||
653 | |a bone remodeling | ||
653 | |a DAPK | ||
653 | |a ERK | ||
653 | |a p38 | ||
653 | |a JNK | ||
653 | |a mitogen-activated protein kinase pathway (MAPK pathway) | ||
653 | |a protein tyrosine phosphatase interacting protein 51 (PTPIP51) | ||
653 | |a protein-protein interaction (PPI) | ||
653 | |a cancer signaling | ||
653 | |a SR | ||
653 | |a CR | ||
653 | |a Compatibility | ||
653 | |a T2DM | ||
653 | |a metabolic profiling | ||
653 | |a MAPK/PI3K/Akt signaling pathway | ||
653 | |a reactive oxygen species | ||
653 | |a PTPN6 | ||
653 | |a SRC | ||
653 | |a DOK4 | ||
653 | |a MKK4 | ||
653 | |a MKK7 | ||
653 | |a p53 | ||
653 | |a DUSP1 | ||
653 | |a SIRT2 | ||
653 | |a atherosclerosis | ||
653 | |a aortic valve sclerosis | ||
653 | |a aortic valve stenosis | ||
653 | |a naphthalimide-metal complex conjugates | ||
653 | |a N-heterocyclic carbene | ||
653 | |a mitochondria | ||
653 | |a ROS | ||
653 | |a p38 MAPK | ||
653 | |a cancer | ||
653 | |a FGF-induced signaling | ||
653 | |a FRS2 | ||
653 | |a phosphorylation | ||
653 | |a downregulation | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/2405 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/68643 |7 0 |z DOAB: description of the publication |